Revvity | PKI - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Agilent USD 990M 44M 2026-03
Align Technology USD 736.59M 53M 2026-03
Bio Techne USD 208.29M 17.01M 2026-03
Bio-Rad Laboratories USD 345.2M 1.8M 2025-12
Bruker USD 379.8M 69.4M 2026-03
Celltrion KRW 39.29B 7.7B 2026-03
Charles River Laboratories USD 279.32M 7.36M 2026-03
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Danaher USD 3.59B 375M 2026-03
Dentsply International USD 427M 16M 2026-03
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Illumina USD 721M 38M 2026-03
Intuitive Surgical USD 2.02B 193.4M 2026-06
IQVIA Holdings USD 1.07B 52M 2026-03
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Laboratory Of America USD 1.01B 20.6M 2026-03
Medical Developments International AUD 7.35M 7.37M 2025-06
Mesa Laboratories USD 39.75M 4.3M 2024-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
OraSure Technologies USD 11.34M 435K 2025-12
Organigram Holdings CAD 16.41M 6.91M 2026-03
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Pharma Mar EUR 39.24M 47.46M 2026-03
Qiagen NV USD 325.27M 19.53M 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Quidel USD -91.8M 366.6M 2026-03
Repligen USD 108.28M 4.45M 2026-03
Revvity USD 387.66M 34M 2026-03
Sartorius EUR 414.5M 18.3M 2026-03
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Tilray USD 57.47M 10.16M 2025-06
Waters USD 542M 15.42M 2026-03
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03